It has just given its verdict on several small-cap ASX shares. Here's what it is recommending:

Mach7 Technologies Ltd (ASX: M7T)

Securities Vault has named Mach7 as a small-cap ASX share to buy.

It believes the enterprise imaging platform provider is well-placed to grow its recurring revenue thanks to expanding budgets in the US healthcare sector. It explains:

The company provides enterprise imaging platforms used by hospitals across the globe, positioning it as a scalable SaaS (software-as-a-service) style health technology play. Recent quarterly updates have shown improving cost discipline and operating leverage. The real upside lies in recurring revenue growth and contract wins across North America, where healthcare information technology budgets are structurally expanding.

As hospitals modernise legacy systems, Mach7's vendor-neutral archive (VNA) offering becomes increasingly relevant. If management continues to convert its pipeline into contracts, the market could materially re-rate earnings visibility. At current levels, it still trades at a discount to global peers despite similar growth characteristics.

Oneview Healthcare (ASX: ONE)

Another small-cap ASX share that Securities Vault rates as a buy is Oneview Healthcare.

It is feeling positive about the care experience platform provider's outlook due to favourable funding tailwinds in the US market. It explains:

Its care experience platform integrates patient engagement tools into hospital systems. The company's offering should generate demand. Potential upside exits following positive momentum. The investment thesis hinges on hospital digitisation and patient experience mandates, particularly in the US, where funding tailwinds remain supportive.

As deployments scale up, Oneview's recurring revenue model should drive operating leverage. Importantly, the company has already secured major hospital clients, reducing execution risk compared to earlier stage peers.

WRKR Ltd (ASX: WRK)

One small-cap ASX share that Securities Vault isn't positive on is WRKR. It has named the workforce compliance and payroll solutions company's shares as a sell this week.

Securities Vault has concerns over elevated execution risks and an uncertain pathway to profitability. It explains:

The company operates in workforce compliance and payroll solutions—an attractive theme—but execution risk remains elevated, in our view. Despite operating in a growing sector, the pathway to profitability remains uncertain. The company posted a loss after tax of $2.66 million in the first half of 2026. Investors chasing the theme may be better served in bigger, more established platforms offering stronger execution capabilities.

The post Buy, hold, sell: 3 small cap ASX shares appeared first on The Motley Fool Australia.

For those unfamiliar, Wrkr is a financial technology company.

It engages in the design of innovative overlay capability for banking, wealth management, pensions, and financial services. Its activities include ClickSuper, which provides clearing house services for large employers and small medium enterprises. 

What did the company report?

Last week, the company released a quarterly report, which included: 

• Cash Receipts: $4.3 million, driven by recurring Wrkr PAY transactional activity, feature development for Precision Administration, and integration of PaidRight revenue
• Operating Outflows: $6.4 million, reflecting strategic investment in 14 new FTEs to bolster delivery and operational support, the acquisition of PaidRight, and increased investment in marketing our direct-to-market clearinghouse
• Strategic Capital Investment: $2.1 million invested to ensure platform scalability, data migration, and continued API development to capture potential opportunities with new Digital Service Providers

Speaking on the results, Wrkr CEO, Trent Lund said: 

This quarter was about proving Wrkr can deliver. Seeing large employers transition to Rest Pay and AustralianSuper is a powerful validation of our technology and our capacity to execute.

We are proactively collaborating with our clients to accelerate adoption. We recognise that, while large enterprises are leading the charge, the mid-market and small-business segments are working through their own transition timelines. We are ready for them, and we remain laser-focused on scaling our transaction revenue as these businesses onboard onto our infrastructure.

What is Morgans' view on this small cap?

This week, the team at Morgans released updated guidance on this ASX small-cap. 

Interestingly, the broker said that while cash outflows have increased to support growth, the business appears to be tracking well operationally. Accordingly, this is highlighted by the successful live launches of REST Pay and AustralianSuper. 

Off low bases, we lift our WRK FY26F EPS by +7% but lower our FY27F EPS by 6% on a broad review of our earnings assumptions. Our target price is unchanged at A$0.14. We continue to think WRK is well positioned for a significant earnings inflection point in FY27, and we maintain our BUY recommendation.

On Friday, this ASX small-cap closed trading at 12 cents per share. 

The 14 cents per share target from Morgans indicates a potential upside of approximately 17% for this ASX small cap. 

The post Morgans has a buy recommendation on this ASX small cap  appeared first on The Motley Fool Australia.

This largely focuses on quality, blue-chip companies and diversified ASX ETFs.

However, there is no denying that ASX small-caps can be a profitable allocation in any portfolio. 

So if you are looking to sprinkle an allocation into ASX small-caps with upside potential, these three have drawn positive attention from brokers following their recent results.

Oneview Healthcare PLC (ASX: ONE)

Oneview Healthcare provides interactive patient care

The company's Care Experience Platform (CXP) is a unified set of digital tools in a single bedside solution that connects patients, families and care teams with services, education, and information during hospital stays.

A recent report from Bell Potter has indicated ASX small-cap could double in value over the next year. 

The company recently released a quarterly report.

Following this, Bell POtter retained its speculative buy recommendation and price target of 45 cents. 

From yesterday's closing price of 17.5 cents, this indicates a potential upside of 157%. 

Bell Potter did note that while the company expects ~20% growth in live endpoints driven by a strong pipeline, execution risk remains as investors await faster conversion and stronger revenue growth, with valuation unchanged and caution maintained until consistent financial performance is demonstrated.

Despite improving thematics and the need for hospitals to utilise efficiency tools to plug the operating impact of nurse shortages, we remain cautious ahead of more consistent performance on conversion and financial performance.

WRKR Ltd (ASX: WRK)

WRKR is a financial technology company, which engages in the design of innovative overlay capability for banking, wealth management, pensions, and financial services.

It also recently released a quarterly report.

Following the release, Bell Potter reaffirmed buy recommendation, however reduced its share price target to 17.5 cents.

This target is a healthy 57% higher than yesterday's closing price. 

The broker noted it was impressed with a reported record cash receipts of $4.3m, including payment of $0.9m outstanding invoices and $0.7m PaidRight customer invoices. 

WRK has seen further acceleration in large scale-execution and de-risking. The next quarter is catalyst rich, with transaction revenue expected to scale, balancing investments.

Mach7 Technologies Ltd (ASX: M7T)

This ASX small-cap is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations.

Last week, it released Q3 FY26 results.

This prompted an unchanged buy recommendation from Morgans, with an updated price target of 44 cents per share. 

The broker noted a lower operating cost base sets the company up well for better operating leverage from FY27.

From yesterday's closing price of 27.5 cents, this indicates an upside potential of approximately 60%. 

The post 3 ASX small-cap stocks every investor should be monitoring appeared first on The Motley Fool Australia.

That's the view of the team at Morgans, which has just put a buy rating on the growing company's shares.

Which small-cap ASX share?

The small cap that Morgans is tipping as a buy is WRKR Ltd (ASX: WRK).

Wrkr is an Australian financial technology company that provides compliance and payment software solutions to create efficiencies for superfunds, payroll service providers, and both large and small Australian employers.

The small-cap ASX share highlights that it has three core offerings.

The first is Wrkr PLATFORM, which is a modern cloud-based compliance platform for handling messaging with the ATO and orchestrating payment processing for worker pay and super contributions for Fund Administrators.

It also offers Wrkr PAY, which is a superannuation gateway and clearinghouse and payment handling solution for processing of employee pay and super contributions for payrolls and superfunds. This includes Wrkr SMSF Hub, which provides ATO messaging and contributions compliance for SMSFs.

Lastly, it offers Wrkr READY, which is a white-label employee onboarding solution to manage the compliant onboarding of full-time and casual workers.

What did the broker say?

Morgans believes that this small-cap ASX share is on the brink of turning a profit following a critical transition year.

And with a strong balance sheet and tailwinds in its sails, the broker believes it is positioned for sustainable growth. It said:

Wrkr (WRK) is an Australian regtech company that helps employers simplify workforce compliance across the hire to retire lifecycle. FY26 is a critical transition year for WRK, with the onboarding of large client wins setting it up to turn a profit in FY27. With a strong balance sheet (A$16m of cash at 1H26) and playing in markets supported by regulatory tailwinds, we think WRK is well positioned to deliver sustainable growth. We initiate coverage on WRK with a BUY recommendation, with the stock trading at a ~25% discount to our blended valuation of A$0.14 per share.

As mentioned above, Morgans has initiated coverage on the small-cap ASX share with a buy rating and 14 cents price target.

Based on its current share price, this implies potential upside of 25% for investors over the next 12 months.

The post Morgans just slapped a buy rating on this small-cap ASX share appeared first on The Motley Fool Australia.

That's because they have just been named as buys by analysts at Bell Potter. Here's why the broker is bullish on these names:

6K Additive Inc (ASX: 6KA)

The first small cap ASX share that Bell Potter is tipping as a buy is 6K Additive.

It is a US-based manufacturer, upcycling metal scrap into premium metal powders and alloying additives. Bell Potter highlights that its patented UniMelt technology can produce spherical powders for additive manufacturing across a range of high-end reactive metals, refractory metals, and alloys.

This includes titanium, Inconel, C103 and tantalum. Compared with incumbent spheroidisation processes, UniMelt has materially lower energy consumption, achieves higher product yield, and upcycles manufacturing waste.

The broker believes the small cap has a competitive advantage and is well-placed to benefit from increased defence spending. It said:

6KA has a competitive advantage in the production of high-value metal powders for the fast-growing global Additive Manufacturing sector. The company's UniMelt systems are energy efficient, high yield and accept recycled metal feedstock. 6KA is supporting US-based reshoring of critical metal supply.

Company value is highly leveraged to the take-up of Additive Manufacturing, which has lead-time advantages over incumbent casting and forging production methods. We expect Additive Manufacturing to be a beneficiary of the US Department of War's Acquisition Transformation Strategy to support rebuilding the country's Defense Industrial Base.

Bell Potter has a speculative buy rating and $1.45 price target on its shares.

WRKR Ltd (ASX: WRK)

Another small cap ASX share that Bell Potter is bullish on is WRKR. It is a regulation technology company for Australian employers across the employee lifecycle. The company has a core focus on managing superannuation compliance events, providing payment processing and onboarding solutions.

Bell Potter was pleased with the company's performance during the second quarter. It said:

WRK delivered another standout cash collection result, with $3.2m cash receipts from customers in 2Q26. The print was negatively impacted by $0.9m late invoices which have since been collected. This is expected to benefit the 3Q26 result.

Cash receipts, adjusted for timing differences, grew +68% YOY and +13% QOQ pro-forma reflecting: 1) consistent recurring revenue linked to transactional activity through Wrkr PAY (71% FY25 revenue); 2) Ongoing developments for Australian Retirement Trust, with their Employer Online portal being a new mention, and further work on the Beam platform; and 3) milestone payments related to MUFG Australian and Hong Kong agreements, in addition to monthly support and maintenance fees for the Hong Kong platform.

In response, the broker has retained its buy rating with an improved price target of 18.5 cents.

The post Bell Potter names 2 small cap ASX shares to buy appeared first on The Motley Fool Australia.